JP3074655B2 - Prefilled syringe for two components - Google Patents

Prefilled syringe for two components

Info

Publication number
JP3074655B2
JP3074655B2 JP03349131A JP34913191A JP3074655B2 JP 3074655 B2 JP3074655 B2 JP 3074655B2 JP 03349131 A JP03349131 A JP 03349131A JP 34913191 A JP34913191 A JP 34913191A JP 3074655 B2 JP3074655 B2 JP 3074655B2
Authority
JP
Japan
Prior art keywords
sealing member
compression
plunger
syringe
rod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP03349131A
Other languages
Japanese (ja)
Other versions
JPH05154198A (en
Inventor
準 二川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP03349131A priority Critical patent/JP3074655B2/en
Publication of JPH05154198A publication Critical patent/JPH05154198A/en
Application granted granted Critical
Publication of JP3074655B2 publication Critical patent/JP3074655B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は2成分用プレフィルドシ
リンジに関し、より詳しくは、注射器の内部が2室に区
画されており、一方の室には薬液(溶解液を含む)が、
他方の室には薬液または粉末製剤や固形製剤などの乾燥
薬剤が予め収納されてなる注射器であって、そうするこ
とによって封入された薬液や乾燥薬剤が変質することな
く保存することができ、注射に際して2室に区画されて
封入された薬液と薬液(または乾燥薬剤)とを混合する
ことができるようにした2成分用プレフィルドシリンジ
に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a two-component prefilled syringe, and more particularly, the interior of a syringe is divided into two chambers, one of which contains a drug solution (including a solution).
The other chamber is a syringe in which a dry drug such as a drug solution or a powder formulation or a solid formulation is stored in advance, so that the sealed drug solution or the dry drug can be stored without deterioration, and the injection can be performed. The present invention relates to a two-component prefilled syringe capable of mixing a drug solution and a drug solution (or a dry drug) partitioned and sealed in two chambers.

【0002】[0002]

【従来の技術】注射可能な薬剤の中には、例えば固形製
剤や粉末製剤の様に、あるいはアミノ酸液とぶどう糖液
の様に、これらが使用可能な状態に置かれた時に変質し
て急速に薬効が失われるものがある。そこでこれらの薬
剤の長期の保存を可能成らしめ、かつ用時に無菌的に素
早く調製できるようにするものとして、従来、注射器の
内部が2室に区画されており、一方の室には薬液(溶解
液を含む)が、他方の室には薬液または粉末製剤や固形
製剤などの乾燥薬剤が予め収納されてなる注射器いわゆ
る2成分用プレフィルドシリンジが採用されている。
2. Description of the Related Art Some injectable drugs, such as solid preparations or powdered preparations, or amino acid solutions and glucose solutions, deteriorate and rapidly change when they are put into use. Some drugs lose their efficacy. Therefore, in order to make it possible to store these drugs for a long period of time and to aseptically prepare them aseptically at the time of use, the interior of a syringe has conventionally been divided into two chambers, and one chamber has a drug solution (dissolution medium). The other chamber employs a so-called two-component prefilled syringe in which a drug solution or a dry preparation such as a powder preparation or a solid preparation is stored in advance.

【0003】このような2成分用プレフィルドシリンジ
としては、注射筒と2室を隔てる摺動閉塞子(以下、隔
壁用ガスケットという)の間にバイパスができるように
したもの(実公昭49−14465号公報、実公昭54
−22315号公報、特公平2−32898号公報、特
開昭60−72561号公報、特開昭61−48377
号公報)や、隔壁用ガスケットそのものにバイパスがで
きるようにしたもの(特開昭59−155264号公
報)、バイパスプランジャの一方向への駆動が希釈圧力
を発生して、希釈剤がプランジャの周囲を通過できるよ
うにしたもの(特開昭58−212453号公報)など
がある。
[0003] As such a two-component prefilled syringe, one in which a bypass can be provided between a sliding obturator (hereinafter, referred to as a partition wall gasket) that separates the syringe from the two chambers (Japanese Utility Model Publication No. 49-14465). Gazette
-22315, JP-B-2-32898, JP-A-60-72561, JP-A-61-48377.
Japanese Patent Application Laid-Open No. 59-155264, and a device in which a bypass is provided in a gasket itself for partition walls (JP-A-59-155264). (JP-A-58-212453).

【0004】実公昭49−14465号公報に示される
注射器は、注射筒の中央部内壁に縦溝状構造を設け、隔
壁用ガスケットの長さを縦溝の長さよりも短くしたもの
であり、実公昭54−22315号公報に示される注射
器は、注射筒の内壁に隔壁用ガスケットの長さよりも長
い細管を固着したものであり、特公平2−32898号
公報に示される注射器は、注射筒の前端に隣接する部分
の内壁を隔壁用ガスケットの長さより僅かに長い長さに
渡って局部的に変形したものである。また、特開昭60
−72561号公報に示される二重隔室形注射器は、注
射筒の内壁を外側または内側に隆起させてバイパスゾー
ンを形成したもので、バイパスゾーンの長さは隔壁用ガ
スケットの長さよりも長くなっている。また、特開昭6
1−48377号公報に示される2医薬成分注射器は、
前記特開昭60−72561号公報に示される二重隔室
形注射器と同様の構成のものであるが、バイパスゾーン
の長さは隔壁用ガスケットの長さよりも短くなってお
り、隔壁用ガスケットの遠端部側のリブに溝を設けてい
る。
In the syringe disclosed in Japanese Utility Model Publication No. 49-14465, a vertical groove-like structure is provided on the inner wall of the central portion of the injection cylinder, and the length of the gasket for the partition wall is shorter than the length of the vertical groove. The syringe disclosed in Japanese Patent Publication No. 54-22315 is a syringe in which a thin tube longer than the length of a gasket for a partition wall is fixed to an inner wall of a syringe barrel. The syringe described in Japanese Patent Publication No. 2-32898 is a front end of the syringe barrel. The inner wall of a portion adjacent to the partition wall is locally deformed over a length slightly longer than the length of the partition gasket. Also, Japanese Patent Application Laid-Open
In the double-compartment syringe disclosed in Japanese Patent Application Laid-Open No. 7-25661, a bypass zone is formed by protruding the inner wall of an injection tube outward or inward, and the length of the bypass zone is longer than the length of the gasket for the partition wall. ing. In addition, Japanese Unexamined Patent Publication
The two-drug syringe shown in Japanese Patent No.
It has the same configuration as the double-compartment syringe shown in JP-A-60-72561, except that the length of the bypass zone is shorter than the length of the gasket for the partition wall. A groove is provided in the rib on the far end side.

【0005】一方、特開昭58−212453号公報に
示される医薬用多室容器は、バイパスプランジャと、こ
のバイパスプランジャ内にシート部を形成する手段と、
上記シート部内に係合する先端部を有するプランジャロ
ッドとを備えており、バイパスプランジャが管状容器内
で前方へ変移した時、先端部がプランジャのディスク状
基部を径方向に膨張させ、長い在庫有効期間の間、管状
容器を強固にシールできるようになっている。そしてこ
の膨張圧力は、プランジャロッドが混合工程において後
方へ移動する時、僅かに小さくなり、プランジャの動
き、およびプランジャ周囲の希釈剤の流動を容易にする
ようになっている。
On the other hand, the medical multi-chamber container disclosed in Japanese Patent Application Laid-Open No. 58-212453 has a bypass plunger, a means for forming a seat in the bypass plunger,
A plunger rod having a distal end engaged in the seat portion, wherein when the bypass plunger is displaced forward in the tubular container, the distal end expands the disc-shaped base of the plunger in the radial direction, and a long stock available. During the period, the tubular container can be tightly sealed. The inflation pressure is then slightly reduced as the plunger rod moves rearward in the mixing process to facilitate movement of the plunger and flow of diluent around the plunger.

【0006】しかしながら、このような多くの従来技術
が有りながら、一方または両方の成分が液状である2つ
の成分の薬品の長期の保存を可能ならしめ、かつ用時に
無菌的に素早く調製できる、簡易で、信頼性が高く、製
造が容易な注射器に対する需要が以前として存在するの
が実状である。。
[0006] However, despite the many prior arts described above, it is possible to provide a long-term preservation of a two-component drug in which one or both components are in a liquid state, and it can be prepared aseptically and quickly at the time of use. In fact, there is still a need for a reliable and easy to manufacture syringe. .

【0007】[0007]

【発明の解決しようとする課題】本発明は、上記の事情
に鑑みてなされたもので、2つの成分の薬剤の長期の保
存を可能ならしめ、かつ用時に無菌的に素早く調製でき
る、簡易で、信頼性が高く、製造が容易な注射器を提供
することを目的とする。
DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and enables a long-term preservation of a drug of two components, and is simple and easy to prepare aseptically when used. It is an object of the present invention to provide a syringe which is highly reliable and easy to manufacture.

【0008】[0008]

【課題を解決するための手段】本発明は、上記の課題を
解決するために、注射筒の先端のチップおよび後端の開
口部分がそれぞれ第1の密封部材および第2の密封部材
で閉鎖されるとともに、その先端に第3の密封部材を有
するプランジャが、前記第2の密封部材の軸方向に形成
されたロッド挿通孔に流体密に挿通されており、前記第
3の密封部材によって流体密に区画された2つの室にそ
れぞれ薬液および、薬液または乾燥薬剤が予め充填され
てなるシリンジにおいて、前記第2の密封部材および第
3の密封部材が注射筒の内壁を摺動可能であり、前記プ
ランジャのロッドが前記ロッド挿通孔の内壁を摺動可能
であるとともに、該ロッドの先端には密封部材圧縮手段
が設けられており、前記第3の密封部材が前記密封部材
圧縮手段によって圧縮されて拡径されており、該密封部
材圧縮手段による圧縮が解除された時に、第3の密封部
材が元の大きさに復元して注射筒の内壁から離隔し前記
2室が連通するように構成されてなる2成分用プレフィ
ルドシリンジを採用している。ここで、密封部材圧縮手
段は、ロッドの先端部の外壁に取り付けられた圧縮部材
と、螺合部と装着部を有しその径の細い螺合部でロッド
の先端に回動自在に螺合される密封部材装着部材からな
り、第3の密封部材の厚肉な下縁部分が前記圧縮部材と
密封部材装着部材の装着部の間に挟持されている構成が
好ましい。また、第2の密封部材と密封部材圧縮手段の
圧縮部材に、両者を相互に係合して第2の密封部材と第
3の密封部材を一体化する密封部材一体化手段を設けた
構成にしてもよい。
SUMMARY OF THE INVENTION According to the present invention, in order to solve the above-mentioned problems, a tip and an opening at a rear end of a syringe barrel are closed by a first sealing member and a second sealing member, respectively. A plunger having a third sealing member at the tip thereof is fluid-tightly inserted into a rod insertion hole formed in the axial direction of the second sealing member, and is fluid-tight by the third sealing member. In a syringe in which a drug solution and a drug solution or a dry drug are pre-filled in the two chambers partitioned by, the second sealing member and the third sealing member are slidable on the inner wall of the injection cylinder, The rod of the plunger is slidable on the inner wall of the rod insertion hole, and a sealing member compressing means is provided at the tip of the rod, and the third sealing member is moved by the sealing member compressing means. When the compression by the sealing member compressing means is released, the third sealing member is restored to its original size, separated from the inner wall of the syringe barrel, and communicates with the two chambers. The pre-filled syringe for two components constituted as described above is adopted. Here, the sealing member compression means has a compression member attached to the outer wall of the distal end portion of the rod, a threaded portion and a mounting portion, and is rotatably screwed to the distal end of the rod by a threaded portion having a small diameter. Preferably, the third sealing member has a thick lower edge portion sandwiched between the compression member and the mounting portion of the sealing member mounting member. Further, the second sealing member and the compression member of the sealing member compression means are provided with sealing member integration means for mutually engaging the two and integrating the second sealing member and the third sealing member. You may.

【0009】[0009]

【作用】本発明の構成によれば、流体密に区画された2
つの室の連通は図3に示す様に行われる。すなわち図4
に示すようにプランジャ7を時計方向に回転させると、
第3の密封部材6が密封部材装着部材13に装着されて
おり、この第3の密封部材6が注射筒1の内壁に係合さ
れて動かないので、プランジャ7は上方に移動し、圧縮
部材14と密封部材装着部材13の装着部16の間隔が
拡がり、第3の密封部材6の下縁部分17が元の大きさ
に復元して注射筒1の内壁から離れ、注射筒1と第3の
密封部材6の間に隙間18ができる。すると注射筒1の
第2の密封部材5と第3の密封部材6で囲まれた室19
に収容された薬液(溶解液を含む)10は第1の密封部
材3と第3の密封部材6で囲まれた室20に流れ込み、
室20に収容された乾燥薬剤11を溶解する(または薬
液と混合する)。また、2つの室19、20が連通され
た後、図4に示すようにプランジャ7を上方に引いて圧
縮部材14を第2の密封部材5の密封部材係合窩21に
装着すれば第2の密封部材5と第3の密封部材6は一体
化される。この状態でプランジャ7を反時計方向に回転
させると、今度はプランジャ7が下方に移動し、圧縮部
材14と密封部材装着部材13の装着部16の間隔が狭
まり、第3の密封部材6の下縁部分17が拡径して注射
筒1の内壁に密着し、注射筒1の内壁を流体密にシール
する。薬液を注射する時には、チップ2から第1の密封
部材3を外してプランジャ7を下方に移動させればよ
い。
According to the configuration of the present invention, the fluid-tight partitioned 2 is provided.
The communication between the two chambers is performed as shown in FIG. That is, FIG.
When the plunger 7 is rotated clockwise as shown in FIG.
Since the third sealing member 6 is mounted on the sealing member mounting member 13 and the third sealing member 6 is engaged with the inner wall of the syringe barrel 1 and does not move, the plunger 7 moves upward and the compression member is moved. The interval between the mounting member 16 and the mounting portion 16 of the sealing member mounting member 13 is widened, and the lower edge portion 17 of the third sealing member 6 is restored to its original size and separated from the inner wall of the syringe tube 1. A gap 18 is formed between the sealing members 6. Then, the chamber 19 surrounded by the second sealing member 5 and the third sealing member 6 of the syringe barrel 1
The chemical solution (including the dissolving solution) 10 contained in the container flows into the chamber 20 surrounded by the first sealing member 3 and the third sealing member 6,
The dry medicine 11 housed in the chamber 20 is dissolved (or mixed with the drug solution). After the two chambers 19 and 20 are communicated with each other, as shown in FIG. 4, the plunger 7 is pulled upward to attach the compression member 14 to the sealing member engaging hole 21 of the second sealing member 5, and the second The sealing member 5 and the third sealing member 6 are integrated. When the plunger 7 is rotated in the counterclockwise direction in this state, the plunger 7 moves downward this time, so that the interval between the compression member 14 and the mounting portion 16 of the sealing member mounting member 13 is narrowed, and the lower portion of the third sealing member 6 The rim portion 17 expands in diameter and closely adheres to the inner wall of the syringe barrel 1 to seal the inner wall of the syringe barrel 1 in a fluid-tight manner. When injecting a drug solution, the first sealing member 3 may be removed from the tip 2 and the plunger 7 may be moved downward.

【0010】[0010]

【実施例】次に本発明の実施例について図面に基づいて
説明する。図1は本発明の一実施例を示す断面図であ
り、図2は他の実施例を示す要部断面図、図3は区画さ
れた2室の連通操作を説明する図、図4は第2の密封部
材と第3の密封部材を一体化する操作を説明する図であ
る。また、図5は本発明のプレフィルドシリンジの使用
状況説明図である。図1に示すように、本発明のプレフ
ィルドシリンジは、注射筒1と、この注射筒1に挿着さ
れた、先端に第3の密封部材6を有するプランジャ7
と、注射筒1の先端のチップ2に装着された第1の密封
部材3と、注射筒1の基端部開口4に挿着された第2の
密封部材5からなり、第2の密封部材5には軸方向にロ
ッド挿通孔9が形成されている。そして第3の密封部材
6は、プランジャ7のロッド8の先端に設けられた密封
部材圧縮手段12によって圧縮され拡径されて、注射筒
1の内部を2室19、20に区画しており。この2室1
9、20の連通は密封部材圧縮手段12による圧縮が解
除されることにより達成されるようになっている。
Next, an embodiment of the present invention will be described with reference to the drawings. FIG. 1 is a cross-sectional view showing one embodiment of the present invention, FIG. 2 is a cross-sectional view of a main part showing another embodiment, FIG. 3 is a diagram for explaining a communication operation of two partitioned chambers, and FIG. It is a figure explaining operation which unifies the 2nd sealing member and the 3rd sealing member. FIG. 5 is an explanatory view of the use situation of the prefilled syringe of the present invention. As shown in FIG. 1, the prefilled syringe of the present invention comprises a syringe 1 and a plunger 7 having a third sealing member 6 at the end inserted into the syringe 1.
A first sealing member 3 attached to the tip 2 at the distal end of the syringe barrel 1, and a second sealing member 5 inserted into the base end opening 4 of the syringe barrel 1. 5 has a rod insertion hole 9 formed in the axial direction. The third sealing member 6 is compressed and expanded in diameter by a sealing member compression means 12 provided at the tip of the rod 8 of the plunger 7, and partitions the inside of the syringe barrel 1 into two chambers 19 and 20. These two rooms 1
The communication between 9 and 20 is achieved by releasing the compression by the sealing member compression means 12.

【0011】注射筒1は通常の注射筒同様、先端に薬液
の注出口であるチップ2を有し、基端部に指を懸けるた
めのフランジ23を有しており、透明な合成樹脂のたと
えばポリプロピレンやポリエステル、ポリスチレン、ポ
リカーボネートなどで断面円形に形成されている。そし
てチップ2の開口は第1の密封部材3で閉鎖され、フラ
ンジ23側の開口4は第2の密封部材5で閉鎖されてお
り、フランジ23には通常ストッパー24が取りつけら
れている。ストッパー24により第2の密封部材5が注
射筒1から脱落しないようになっている。
The syringe barrel 1 has a tip 2 which is a drug solution outlet at the distal end and a flange 23 for hanging a finger at the base end, like a normal syringe barrel, and is made of a transparent synthetic resin such as It has a circular cross section made of polypropylene, polyester, polystyrene, polycarbonate, or the like. The opening of the chip 2 is closed by the first sealing member 3, the opening 4 on the flange 23 side is closed by the second sealing member 5, and the flange 23 is usually provided with a stopper 24. The stopper 24 prevents the second sealing member 5 from dropping from the syringe barrel 1.

【0012】第1の密封部材3は、一般にポリエチレン
や軟質塩化ビニル樹脂などの軟質の可撓性樹脂や、ブチ
ルゴムやブタジエンゴム、スチレン−ブタジエンゴム、
イソプレンゴム、ニトリルゴム、エチレン−プロピレン
ゴムなどのゴム状弾性体などを用いて、通常図1に示す
ようにチップ2に外嵌する形状に形成されるが、チップ
2の開口から挿着するように形成してもよく、これと第
3の密封部材6との間に乾燥薬剤11(または薬液)を
収容する室20が形成される。一方、第2の密封部材5
は、一般に第1の密封部材3に用いるゴム状弾性体と同
様のゴム状弾性体を用いて、フランジ23側の開口4に
挿着される形状に形成されており、これと第3の密封部
材6との間に薬液(溶解液を含む)を収容する室19が
形成されている。そして第2の密封部材5にはその軸方
向に貫通するロッド挿通孔9が形成されており、この孔
にはプランジャ7のロッド8が流体密に挿入されてい
る。
The first sealing member 3 is generally made of a soft flexible resin such as polyethylene or soft vinyl chloride resin, butyl rubber, butadiene rubber, styrene-butadiene rubber,
As shown in FIG. 1, a rubber-like elastic body such as isoprene rubber, nitrile rubber, and ethylene-propylene rubber is used. A chamber 20 for accommodating the dry medicine 11 (or chemical solution) is formed between the third sealing member 6 and the third sealing member 6. On the other hand, the second sealing member 5
Is formed in a shape to be inserted into the opening 4 on the flange 23 side by using a rubber-like elastic body similar to the rubber-like elastic body generally used for the first sealing member 3. A chamber 19 for containing a chemical solution (including a solution) is formed between the member 6 and the member 6. The second sealing member 5 has a rod insertion hole 9 penetrating in the axial direction thereof, and the rod 8 of the plunger 7 is inserted in this hole in a fluid-tight manner.

【0013】第2の密封部材5には、必要ならば、プラ
ンジャ7を反時計方向に回転させた時に第3の密封部材
6が回転しないように、第3の密封部材6側に、プラン
ジャ7先端の密封部材圧縮手段12の圧縮部材14と相
互に係合する、たとえば段差(図示していない、この場
合圧縮部材14にもこれと係合する段差が設けられる)
などを設けてもよい。また、第2の密封部材5の第3の
密封部材6側には、必要ならば、第2の密封部材5と第
3の密封部材6とを一体化する密封部材一体化手段を設
けてもよく、密封部材一体化手段としては、たとえば図
1に示すような密封部材係合窩21(圧縮部材14の環
状突起26が嵌入される)や、図2に示すような密封部
材螺合窩27(圧縮部材14の雄ネジ28が螺合され
る)などが挙げられる。
If necessary, the second sealing member 5 is provided with a plunger 7 on the third sealing member 6 side so that the third sealing member 6 does not rotate when the plunger 7 is rotated counterclockwise. For example, a step (not shown, the compression member 14 is also provided with a step which engages with the compression member 14) of the distal end sealing member compression means 12 so as to engage with each other.
And the like may be provided. Further, if necessary, a sealing member integrating means for integrating the second sealing member 5 and the third sealing member 6 may be provided on the third sealing member 6 side of the second sealing member 5. As the sealing member integrating means, for example, the sealing member engaging hole 21 (to which the annular projection 26 of the compression member 14 is fitted) as shown in FIG. 1 or the sealing member screwing hole 27 as shown in FIG. (The external thread 28 of the compression member 14 is screwed).

【0014】第2の密封部材5のロッド挿通孔9を通し
て注射筒1内に挿入されるプランジャ7は、先端側が開
口し基端側が閉鎖された中空のロッド8と、このロッド
8の先端部に設けられた密封部材圧縮手段12からなっ
ており、先端には第3の密封部材6を有している。そし
てロッド8の基端には通常指で押しやすいようにフラン
ジ29が設けられており、フランジ29と第2の密封部
材5の間の部分には、プランジャ7が不用意に移動しな
いようにリブ25を設けることもある。
A plunger 7 inserted into the syringe barrel 1 through the rod insertion hole 9 of the second sealing member 5 has a hollow rod 8 opened at the distal end and closed at the proximal end, and a hollow rod 8 at the distal end of the rod 8. It is provided with a sealing member compression means 12 provided, and has a third sealing member 6 at the tip. A flange 29 is provided at the base end of the rod 8 so as to be easily pressed by a finger. A rib is provided at a portion between the flange 29 and the second sealing member 5 so that the plunger 7 does not move carelessly. 25 may be provided.

【0015】密封部材圧縮手段12は、第3の密封部材
6を圧縮して拡径するための手段であり(圧縮されて拡
径するためには、第3の密封部材6はゴム状弾性を有す
る必要がある)、ロッド8の先端からその中空部分22
に挿入され螺合される密封部材装着部材13と、ロッド
8の先端の外壁に取りつけられる圧縮部材14からな
る。そして密封部材装着部材13は、第3の密封部材6
を装着するための装着部16と、ロッド8の中空部分2
2に設けた雌ネジ30と螺合するための雄ネジ31を有
する螺合部15からなる。密封部材装着部材13の装着
部16の上から装着された第3の密封部材6はその厚肉
な下縁部分17が圧縮部材14と装着部16の間に挟ま
れるように配置されており、使用前には、図1に示すよ
うに第3の密封部材6の下縁部分17が圧縮部材14と
装着部16によって圧縮されて拡径し、注射筒1の内壁
に密着している。用時に2室19、20を連通する際に
は、プランジャ7を時計方向に回転することにより、密
封部材装着部材13が第3の密封部材6に嵌入されてい
る関係で動かないため、プランジャ7が上方に移動して
密封部材装着部材13と圧縮部材14の間隔が開き、両
部材13、14による第3の密封部材6の下縁部分17
の圧縮が解除され、下縁部分17が元の大きさに復元し
て注射筒1の内壁から離れ、注射筒1と第3の密封部材
6の間に隙間18ができる様になっている(図3参
照)。
The sealing member compressing means 12 is a means for compressing and expanding the third sealing member 6 (in order to compress and expand the diameter, the third sealing member 6 has rubber-like elasticity. The hollow portion 22 from the tip of the rod 8
And a compression member 14 attached to the outer wall at the tip of the rod 8. The sealing member mounting member 13 is connected to the third sealing member 6.
And a hollow portion 2 of the rod 8.
2 includes a screw portion 15 having a male screw 31 for screwing with a female screw 30 provided in the second screw 2. The third sealing member 6 mounted on the mounting portion 16 of the sealing member mounting member 13 is disposed such that its thick lower edge portion 17 is sandwiched between the compression member 14 and the mounting portion 16. Before use, the lower edge portion 17 of the third sealing member 6 is compressed and expanded by the compression member 14 and the mounting portion 16 as shown in FIG. When the two chambers 19 and 20 communicate with each other during use, the plunger 7 is rotated in a clockwise direction, so that the sealing member mounting member 13 does not move because it is fitted into the third sealing member 6. Moves upward to increase the distance between the sealing member mounting member 13 and the compression member 14, and the lower edge portion 17 of the third sealing member 6 by the two members 13 and 14.
Is released, the lower edge portion 17 is restored to its original size, separated from the inner wall of the syringe barrel 1, and a gap 18 is formed between the syringe barrel 1 and the third sealing member 6 ( (See FIG. 3).

【0016】プランジャ7の先端に設けられた密封部材
装着部材13に装着される第3の密封部材6は、一般に
第2の密封部材5と同様のゴム状弾性体を用いて、注射
器のガスケット状に形成されており、密封部材装着部材
13の装着部16を嵌入するための窩32を有し、その
下縁部分17は図3に示すように装着部16の厚みより
も十分に長く螺合部15方向に延びており、然も内側に
向かって肥厚している。そのため、第3の密封部材6の
下縁部分17を挟むように位置している圧縮部材14と
装着部16とが接近して図3の状態から図1の状態にな
ると、第3の密封部材6の下縁部分17が圧縮部材14
と装着部16に圧迫され拡径し、注射筒1の内壁に密着
するようになっている。一方、逆に圧縮部材14と装着
部16とが離れて図1の状態から図3の状態になると、
第3の密封部材6の下縁部分17は圧縮部材14と装着
部16による圧迫が解除されて縮径し(元の大きさに戻
る)、注射筒1の内壁から離隔するようになっている
The third sealing member 6 mounted on the sealing member mounting member 13 provided at the distal end of the plunger 7 is generally made of the same rubber-like elastic material as the second sealing member 5, and is used in the form of a gasket for a syringe. The lower edge portion 17 is screwed sufficiently longer than the thickness of the mounting portion 16 as shown in FIG. It extends in the direction of the part 15 and is thickened inward. Therefore, when the compression member 14 and the mounting portion 16 located so as to sandwich the lower edge portion 17 of the third sealing member 6 approach each other and change from the state of FIG. 3 to the state of FIG. 1, the third sealing member 6 is the compression member 14
Then, the diameter is increased by being pressed by the mounting portion 16 so as to be in close contact with the inner wall of the syringe barrel 1. On the other hand, when the compression member 14 and the mounting portion 16 are separated from each other and the state of FIG.
The lower edge portion 17 of the third sealing member 6 is released from the compression by the compression member 14 and the mounting portion 16 and is reduced in diameter (returns to its original size) and is separated from the inner wall of the syringe barrel 1.

【0017】次に、本発明のプレフィルドシリンジの使
用について図5を用いて説明する。使用前の状態は図5
のAのように2室19、20が第3の密封部材6によっ
て流体密に区画されている。ここで10は溶解液、11
は粉末薬剤である。用時に、プランジャ7を時計方向に
回転すると、図5のBのように第2の密封部材6が縮径
(元の大きさになる)して2室19、20が連通し、室
19の溶解液10が室20に移動する。次に、プランジ
ャ7を上下に移動させて溶解液10と粉末薬剤を良く混
合した後(5図のC)、必要ならばプランジャ7を引き
上げて第2の密封部材5と第3の密封部材6を一体化し
(図5のD)、第1の密封部材3を除去して注射針やコ
ネクタなどを取付け(図5のE)、プランジャ7を押す
と薬液を排出することができる(図5のF)。
Next, the use of the prefilled syringe of the present invention will be described with reference to FIG. Figure 5 before use
The two chambers 19 and 20 are fluid-tightly partitioned by the third sealing member 6 as shown in FIG. Where 10 is the solution, 11
Is a powdered drug. When the plunger 7 is rotated clockwise during use, the diameter of the second sealing member 6 is reduced (to the original size) as shown in FIG. 5B, and the two chambers 19 and 20 communicate with each other. The lysis solution 10 moves to the chamber 20. Next, the plunger 7 is moved up and down to thoroughly mix the solution 10 and the powdered medicine (C in FIG. 5), and if necessary, the plunger 7 is pulled up to raise the second sealing member 5 and the third sealing member 6. Are integrated (D in FIG. 5), the first sealing member 3 is removed, an injection needle, a connector, and the like are attached (E in FIG. 5), and when the plunger 7 is pressed, the drug solution can be discharged (FIG. 5). F).

【0018】尚、図5では第2の密封部材5と第3の密
封部材6を一体化しているが、第2の密封部材5が注射
筒1の内壁を摺動可能であるため、プランジャ7を引き
上げて両密封部材5、6を接触させた後、プランジャ7
を反時計方向に回転させて第3の密封部材6の下縁部分
17を再び拡径して注射筒1の内壁に密着させるように
すれば、両密封部材5、6は必ずしも一体化する必要は
ない。この場合、第2の密封部材5は第3の密封部材6
との間に生じる陰圧によって引っ張られ、プランジャ7
と一緒に移動する。また、薬剤が高価なばあいには、注
射筒1内に残る薬液が少なくなるので、手間はかかる
が、第3の密封部材6の下縁部分17を再び拡径する様
にした方がよい。
In FIG. 5, the second sealing member 5 and the third sealing member 6 are integrated. However, since the second sealing member 5 can slide on the inner wall of the syringe barrel 1, the plunger 7 To bring the sealing members 5 and 6 into contact with each other, and then the plunger 7
Is rotated counterclockwise to expand the lower edge portion 17 of the third sealing member 6 again so as to be in close contact with the inner wall of the syringe barrel 1, so that the two sealing members 5 and 6 are not necessarily integrated. There is no. In this case, the second sealing member 5 is replaced with the third sealing member 6
And the plunger 7
To move with. When the drug is expensive, the amount of the drug solution remaining in the syringe barrel 1 is reduced, so that it takes time and effort. .

【0019】[0019]

【発明の効果】以上説明してきたことから明らかなよう
に、本発明のプレフィルドシリンジを用いることによ
り、一方または両方の成分が液状である2つの成分の薬
剤の長期の保存が可能であり、用時に無菌的に素早く2
つの成分を混合できる。また、操作が簡便であり、針を
使用していないのでコアリングによる異物が発生するこ
とがなく、安全かつ信頼性の高い調製が可能である。さ
らにまた、複雑な構造をしておらず、部品点数も少ない
ので製造が容易であり、従来のものよりも安価にプレフ
ィルドシリンジを提供することができる。
As is apparent from the above description, the use of the prefilled syringe of the present invention enables long-term storage of a two-component drug in which one or both components are in a liquid state. Sometimes aseptically quickly 2
The two components can be mixed. Further, the operation is simple, and since no needle is used, there is no generation of foreign matter due to coring, and safe and highly reliable preparation is possible. Furthermore, since it does not have a complicated structure and has a small number of parts, it is easy to manufacture, and a prefilled syringe can be provided at a lower cost than conventional ones.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の一実施例を示す断面図である。FIG. 1 is a sectional view showing one embodiment of the present invention.

【図2】本発明の他の実施例を示す要部断面図である。FIG. 2 is a sectional view of a main part showing another embodiment of the present invention.

【図3】図1のプレフィルドシリンジにおいて、区画さ
れた2室の連通操作を説明する図である。
FIG. 3 is a view for explaining a communication operation of two partitioned chambers in the prefilled syringe of FIG. 1;

【図4】図1のプレフィルドシリンジにおいて、第2の
密封部材と第3の密封部材を一体化する操作を説明する
図である。
FIG. 4 is a diagram illustrating an operation of integrating the second sealing member and the third sealing member in the prefilled syringe of FIG.

【図5】本発明のプレフィルドシリンジの使用状況説明
図である。
FIG. 5 is an explanatory view of a use situation of the prefilled syringe of the present invention.

【符号の説明】[Explanation of symbols]

1 注射筒 2 チップ 3 第1の密封部材 5 第2の密封部材 6 第3の密封部材 7 プランジャ 8 ロッド 9 ロッド挿通孔 10 薬液(溶解液) 11 乾燥薬剤(薬液) 12 密封部材圧縮手段 13 密封部材装着部材 14 圧縮部材 15 螺合部 16 装着部 21 密封部材係合窩(密封部材一体化手段) 24 ストッパー 27 密封部材螺合窩(密封部材一体化手段) DESCRIPTION OF SYMBOLS 1 Injection cylinder 2 Tip 3 1st sealing member 5 2nd sealing member 6 3rd sealing member 7 Plunger 8 Rod 9 Rod insertion hole 10 Chemical solution (solution) 11 Dry medicine (chemical solution) 12 Sealing member compression means 13 Sealing Member mounting member 14 Compression member 15 Threaded part 16 Mounting part 21 Sealing member engagement fossil (sealing member integration means) 24 Stopper 27 Sealing member screwing fossilization (sealing member integration means)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 注射筒の先端のチップおよび後端の開口
部分がそれぞれ第1の密封部材および第2の密封部材で
閉鎖されるとともに、その先端に第3の密封部材を有す
るプランジャが、前記第2の密封部材の軸方向に形成さ
れたロッド挿通孔に流体密に挿通されており、前記第3
の密封部材によって流体密に区画された2つの室にそれ
ぞれ薬液および、薬液または乾燥薬剤が予め充填されて
なるシリンジにおいて、前記第2の密封部材および第3
の密封部材が注射筒の内壁を摺動可能であり、前記プラ
ンジャのロッドが前記ロッド挿通孔の内壁を摺動可能で
あるとともに、該ロッドの先端には密封部材圧縮手段が
設けられており、前記第3の密封部材が前記密封部材圧
縮手段によって圧縮されて拡径されており、該密封部材
圧縮手段による圧縮が解除された時に、第3の密封部材
が元の大きさに復元して注射筒の内壁から離隔し前記2
室が連通するように構成されてなる2成分用プレフィル
ドシリンジ。
1. A plunger having a tip at a tip and an opening at a rear end of a syringe barrel closed by a first sealing member and a second sealing member, respectively, and a plunger having a third sealing member at the tip thereof. The third sealing member is fluid-tightly inserted into a rod insertion hole formed in the axial direction of the second sealing member.
A syringe in which two chambers partitioned in a fluid-tight manner by a sealing member are filled with a drug solution and a drug solution or a dry drug, respectively.
Sealing member is slidable on the inner wall of the syringe barrel, the rod of the plunger is slidable on the inner wall of the rod insertion hole, and a sealing member compressing means is provided at the tip of the rod, The third sealing member is compressed and expanded by the sealing member compression means, and when the compression by the sealing member compression means is released, the third sealing member is restored to its original size and injected. 2 away from the inner wall of the cylinder
A two-component prefilled syringe configured to communicate chambers.
【請求項2】 密封部材圧縮手段が、ロッドの先端部の
外壁に取り付けられた圧縮部材と、螺合部と装着部を有
しその径の細い螺合部でロッドの先端に回動自在に螺合
される密封部材装着部材からなり、第3の密封部材の厚
肉な下縁部分が前記圧縮部材と密封部材装着部材の装着
部の間に挟持されている請求項1に記載の2成分用プレ
フィルドシリンジ。
2. A sealing member compression means having a compression member attached to an outer wall of a distal end portion of a rod, a threaded portion and a mounting portion, and a rotatable distal end of the rod at a threaded portion having a small diameter. 2. The two-component component according to claim 1, comprising a sealing member mounting member to be screwed, wherein a thick lower edge portion of the third sealing member is sandwiched between the compression member and the mounting portion of the sealing member mounting member. For prefilled syringes.
【請求項3】 第2の密封部材と密封部材圧縮手段の圧
縮部材に、両者を相互に係合して第2の密封部材と第3
の密封部材を一体化する密封部材一体化手段を設けた請
求項2に記載の2成分用プレフィルドシリンジ。
3. The second sealing member and the compression member of the sealing member compression means are engaged with each other to form the second sealing member and the third sealing member.
The two-component prefilled syringe according to claim 2, further comprising a sealing member integrating means for integrating the sealing member.
JP03349131A 1991-12-06 1991-12-06 Prefilled syringe for two components Expired - Lifetime JP3074655B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03349131A JP3074655B2 (en) 1991-12-06 1991-12-06 Prefilled syringe for two components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03349131A JP3074655B2 (en) 1991-12-06 1991-12-06 Prefilled syringe for two components

Publications (2)

Publication Number Publication Date
JPH05154198A JPH05154198A (en) 1993-06-22
JP3074655B2 true JP3074655B2 (en) 2000-08-07

Family

ID=18401710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03349131A Expired - Lifetime JP3074655B2 (en) 1991-12-06 1991-12-06 Prefilled syringe for two components

Country Status (1)

Country Link
JP (1) JP3074655B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328109A (en) * 2017-01-03 2019-02-12 伊鲁米那股份有限公司 Sample tube with integral type mixing stopper head

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11155951A (en) * 1997-12-01 1999-06-15 Kaken Pharmaceut Co Ltd Decompression syringe and manufacture thereof
JP2002177388A (en) * 2000-12-15 2002-06-25 Daikyo Seiko Ltd Pharmaceutical and medical pre-filled syringe
GB201305489D0 (en) * 2013-03-26 2013-05-08 Consort Medical Plc Improved syringe assembly
CN110917450A (en) 2013-07-16 2020-03-27 尤尼特拉克特注射器公司 Injector for sequential delivery of injectables

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328109A (en) * 2017-01-03 2019-02-12 伊鲁米那股份有限公司 Sample tube with integral type mixing stopper head

Also Published As

Publication number Publication date
JPH05154198A (en) 1993-06-22

Similar Documents

Publication Publication Date Title
US7951108B2 (en) Dual chamber mixing syringe and method for use
US7727183B2 (en) Syringe assembly
US7699811B2 (en) Pre-filled syringe
JPH06327770A (en) Liquid chemicals packing type injector
JPH10295814A (en) Cannula tight sealing shield assembly
JP2005521478A (en) Multi-compartment syringe
WO2004004811A1 (en) Syringe and prefilled syringe
CA2440889A1 (en) Pre-filled safety diluent injector
JP2001112867A (en) Syringe containing drug
JP2006271938A (en) Prefilled syringe
US4563174A (en) Device for mixing several components
JP3074655B2 (en) Prefilled syringe for two components
JP3419145B2 (en) Prefilled syringe
JP3301768B2 (en) Injectable syringe filled with ready-to-use drug
JP2004041568A (en) Two-ingredient mixture type prefilled syringe
JPH07136264A (en) Two-components mixing prefilled injector
WO2018085318A2 (en) Self-contained syringe for dissolution and administration of drugs
JP3141372B2 (en) Two-component prefilled syringe
JP4355151B2 (en) Prefilled syringe and prefilled syringe
JPH07299141A (en) Refilled syringe
GB2210268A (en) Syringe system
JP2002035126A (en) Pre-filled syringe
JPH10243990A (en) Transfusion container provided with mutually communicable three chambers
JP3225497B2 (en) Chemical injection device
WO2024062668A1 (en) Prefilled syringe, distal end member, syringe outer cylinder, and manufacturing method for prefilled syringe